Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Duda

Showing results (161-170 of 222) with videos related to

Pageof 23
Sort By:
Journal of Parkinson'S Disease|September 19, 2017
Statins and Cognition in Parkinson's DiseaseBenjamin L Deck, Jacqueline Rick, Sharon X Xie, et al.
Parkinsonism & Related Disorders|January 2, 2022
Predictors of multi-domain cognitive decline following DBS for treatment of Parkinson's diseaseJohannes C Rothlind, Michele K York, Ping Luo, et al.
Acta Biomaterialia|March 20, 2026
Biopreservation of a tissue engineered nigrostriatal pathway for tract reconstruction in Parkinson's diseaseDimple Chouhan, Kevin D Browne, Wisberty J Gordián Vélez, et al.
The Lancet. Neurology|November 14, 2009
Neuropathological assessment of Parkinson's disease: refining the diagnostic criteriaDennis W Dickson, Heiko Braak, John E Duda, et al.
Parkinsonism & Related Disorders|March 1, 2016
Olfactory impairment predicts cognitive decline in early Parkinson's diseaseMichelle E Fullard, Baochan Tran, Sharon X Xie, et al.
The American Journal of Pathology|November 14, 2000
Widespread nitration of pathological inclusions in neurodegenerative synucleinopathiesJ E Duda, B I Giasson, Q Chen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 8, 2005
Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's diseaseDaniel Weintraub, Andrew B Newberg, Mark S Cary, et al.
Neurology|September 1, 2019
Excessive daytime sleepiness and topographic expansion of Lewy pathologyRobert D Abbott, G Webster Ross, John E Duda, et al.
Journal of Parkinson'S Disease|January 2, 2021
Psychometric Properties of the Clinical Dementia Rating Scale Sum of Boxes in Parkinson's DiseaseJulia Gallagher, Jacqueline Rick, Sharon X Xie, et al.
Neurology|August 4, 2010
Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson diseaseD Weintraub, S Mavandadi, E Mamikonyan, et al.
Pageof 23

Showing results (161-170 of 222) with videos related to

Sort By:
Pageof 23
Journal of Parkinson'S Disease|September 19, 2017
Statins and Cognition in Parkinson's DiseaseBenjamin L Deck, Jacqueline Rick, Sharon X Xie, et al.
Parkinsonism & Related Disorders|January 2, 2022
Predictors of multi-domain cognitive decline following DBS for treatment of Parkinson's diseaseJohannes C Rothlind, Michele K York, Ping Luo, et al.
Acta Biomaterialia|March 20, 2026
Biopreservation of a tissue engineered nigrostriatal pathway for tract reconstruction in Parkinson's diseaseDimple Chouhan, Kevin D Browne, Wisberty J Gordián Vélez, et al.
The Lancet. Neurology|November 14, 2009
Neuropathological assessment of Parkinson's disease: refining the diagnostic criteriaDennis W Dickson, Heiko Braak, John E Duda, et al.
Parkinsonism & Related Disorders|March 1, 2016
Olfactory impairment predicts cognitive decline in early Parkinson's diseaseMichelle E Fullard, Baochan Tran, Sharon X Xie, et al.
The American Journal of Pathology|November 14, 2000
Widespread nitration of pathological inclusions in neurodegenerative synucleinopathiesJ E Duda, B I Giasson, Q Chen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 8, 2005
Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's diseaseDaniel Weintraub, Andrew B Newberg, Mark S Cary, et al.
Neurology|September 1, 2019
Excessive daytime sleepiness and topographic expansion of Lewy pathologyRobert D Abbott, G Webster Ross, John E Duda, et al.
Journal of Parkinson'S Disease|January 2, 2021
Psychometric Properties of the Clinical Dementia Rating Scale Sum of Boxes in Parkinson's DiseaseJulia Gallagher, Jacqueline Rick, Sharon X Xie, et al.
Neurology|August 4, 2010
Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson diseaseD Weintraub, S Mavandadi, E Mamikonyan, et al.
Pageof 23